<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30127" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thymic Hyperplasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Muhammad A.</given-names>
          </name>
          <aff>Montefiore Medical Center/Albert Einstein College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anjum</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>Temple University, Lewis Katz School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Anjum declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30127.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Thymic hyperplasia could be true thymic or lymphoid hyperplasia. It is usually found incidentally or could present with compressive symptoms or systemic symptoms due to autoimmune disease like myasthenia gravis. The diagnosis is made through a chest CT or MRI. Treatment for symptomatic patients is mostly thymectomy. This activity describes pathophysiology, evaluation, and management of thymic hyperplasia and highlights the role of the interprofessional team in the evaluation and treatment of patients with thymic hyperplasia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of thymic hyperplasia.</p></list-item><list-item><p>Review the evaluation of a patient with thymic hyperplasia.</p></list-item><list-item><p>Outline the treatment of a patient with thymic hyperplasia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30127&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30127">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30127.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The thymus got its role in T-cell differentiation discovered a few decades ago before the 1960s it was considered vestigial. Though largely known as a lymphoid organ and for its role in T-cell differentiation, thymus also has an endocrine role that includes manufacturing thymosin that regulates T-cell differentiation and other humoral factors that regulate cell growth, maturation and guide the process of mineralization.<xref ref-type="bibr" rid="article-30127.r1">[1]</xref> The thymus is the principal location for T-cell lymphopoiesis. The production of functional T-cell is choreographed by thymic epithelial cells that guide them in proliferation, maturation, and survival. The thymic epithelial cells are compartmentalized into two main populations medullary thymic epithelial cells and cortical thymic epithelial cells. These populations are further segregated into distinct subpopulations having specific molecular and functional roles.<xref ref-type="bibr" rid="article-30127.r2">[2]</xref></p>
        <p>Thymic hyperplasia alludes to an increase in the size of thymus due to an increase in the number of cells. Thymus achieves its peak size around puberty and then atrophies slowly. Thymic hyperplasia is not always pathological, but the growth of the thymus to a certain degree not anticipated for a patient&#x02019;s age raises the alarm and should lead to further investigation.</p>
      </sec>
      <sec id="article-30127.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>&#x000a0;There are two major etiologies of thymic hyperplasia. It could be congenital or acquired. The congenital thymic hyperplasia can be hypo functioning or hyperfunctioning and is found to be the result of neuroendocrine disturbances, usually within the hypothalamic-hypophyseal system. Thymic hyperplasia with hypo functioning thymus would lead to immune deficiency. Hyperfunctioning thymic hyperplasia could lead to autoimmune diseases, most commonly myasthenia gravis, but the relationship has also been found with graves' disease and collagen vascular disorders. Acquired thymic hyperplasia can also result in hypo functioning or hyperfunctioning thymus.<xref ref-type="bibr" rid="article-30127.r3">[3]</xref><xref ref-type="bibr" rid="article-30127.r4">[4]</xref>&#x000a0;</p>
        <p>Acquired thymic hyperplasia is usually a rebound phenomenon in patients who have undergone chemotherapy, have had thermal burns, cardiac surgery, or after discontinuation of oral steroids as the thymus is susceptible to fluctuations in corticosteroids.</p>
      </sec>
      <sec id="article-30127.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Thymic masses are the most common abnormal growths in the anterior mediastinum. Among the pediatric population, thymic hyperplasia is the most common benign tumor of the anterior mediastinum. In adults, the incidence is increased between the &#x02018;40s and &#x02018;50s; it is similar in men and women. An increased incidence among Asians has been reported compared to other races. Thymic hyperplasia is mostly discovered incidentally in about 50% to 70% of patients with myasthenia gravis. 75% of the patients with myasthenia gravis have thymic disease. Out of 75 %, 85% have thymic hyperplasia, and 10% to 15% have thymoma.</p>
      </sec>
      <sec id="article-30127.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There are two morphological forms of thymic hyperplasia:</p>
        <p><bold>True thymic hyperplasia:</bold>&#x000a0;It is characterized by an increase in the size and weight of thymus due to an increase in the number of thymic epithelial cells. The normal histology of the thymic cells is preserved. This form of thymic hyperplasia is more prevalent among children and young male patients. It is not associated with autoimmune diseases. The most common presentation of this type is usually respiratory distress or peripheral blood lymphocytosis.<xref ref-type="bibr" rid="article-30127.r5">[5]</xref></p>
        <p><bold>Lymphofollicular</bold><bold>&#x000a0;hyperplasia:</bold>&#x000a0;It is caused due to hyperplastic lymph follicles within the thymus. The follicles stem in the medulla and interlobular septal space that shifts the parenchyma of the thymus.<xref ref-type="bibr" rid="article-30127.r6">[6]</xref>&#x000a0;These reactive lymphoid follicles are similar to normal follicles. Histologically these lymphoid follicles have numerous diverse lymphoid cells supplemented with germinal center cells of different sizes and macrophages containing cellular debris. Thus, the main characteristic of&#x000a0;lymphofollicular&#x000a0;thymic hyperplasia is the development of ectopic germinal centers and neo-angiogenesis. This form of thymic hyperplasia is associated with autoimmune diseases like myasthenia gravis or graves' disease.<xref ref-type="bibr" rid="article-30127.r7">[7]</xref></p>
      </sec>
      <sec id="article-30127.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A comprehensive history and a detailed physical examination&#x000a0;are&#x000a0;necessary to&#x000a0;evaluate patients with thymic hyperplasia,&#x000a0;focusing on its signs and symptoms.&#x000a0;Thymic hyperplasia&#x000a0;is usually discovered incidentally after imaging is performed for an unrelated chest complaint. The thymus is located in the anterior mediastinum closely related to airways and major blood vessels. Thymic hyperplasia can compress these structures, causing the following&#x000a0;symptoms:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Shortness&#x000a0;of breath</p>
          </list-item>
          <list-item>
            <p>Dysphagia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cough&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Loss of appetite&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Weight loss&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chest pain</p>
          </list-item>
        </list>
        <p>The thymus is located near the superior vena cava, and a massive true&#x000a0;thymic&#x000a0;hyperplasia could compress it, leading to superior vena cava&#x000a0;syndrome.<xref ref-type="bibr" rid="article-30127.r8">[8]</xref>&#x000a0;The superior vena cava syndrome would present as:&#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Swelling of face, neck, and upper chest&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cyanosis</p>
          </list-item>
          <list-item>
            <p>Headaches</p>
          </list-item>
          <list-item>
            <p>Dizziness</p>
          </list-item>
          <list-item>
            <p>Lightheadedness</p>
          </list-item>
          <list-item>
            <p>Dyspnea</p>
          </list-item>
          <list-item>
            <p>Venous dilatation over the trunk&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Facial Flushing</p>
          </list-item>
          <list-item>
            <p>Stridor</p>
          </list-item>
          <list-item>
            <p>Neurologic signs&#x000a0;</p>
          </list-item>
        </list>
        <p>The&#x000a0;lymphofollicular&#x000a0;thymic hyperplasia is associated with autoimmune diseases like myasthenia gravis, Graves&#x000a0;disease, or collagen vascular disorders. Patients with these autoimmune disorders can present with varying signs and symptoms depending upon the underlying disorder.&#x000a0;&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Myasthenia gravis:</bold>&#x000a0;It is a neurological&#x000a0;autoimmune&#x000a0;disease caused by autoimmunity against the&#x000a0;acetylcholine&#x000a0;receptor component of the neuromuscular junction. The&#x000a0;lymphofollicular&#x000a0;form of thymic hyperplasia is evidently involved in the pathogenesis of myasthenia gravis with&#x000a0;anti-acetylcholine&#x000a0;receptor antibodies.<xref ref-type="bibr" rid="article-30127.r7">[7]</xref>&#x000a0;It is characterized by a fluctuating degree and varying amalgamation of weakness in an ocular, bulbar, limb, and respiratory muscles. T-cell dependent autoantibodies attack the acetylcholine receptors on the postsynaptic membrane leading to muscular weakness.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Graves</bold><bold>&#x000a0;disease:</bold>&#x000a0;The relation between thymic hyperplasia and Graves'&#x000a0;disease was first described in 1912. Patients with Graves'&#x000a0;disease&#x000a0;should undergo a thorough&#x000a0;evaluation&#x000a0;of thymus. There seems to be a complex hormonal and immunological mechanism involved, but the exact pathogenesis is unclear.<xref ref-type="bibr" rid="article-30127.r9">[9]</xref>&#x000a0;Most patients with Graves&#x000a0;disease&#x000a0;can be diagnosed with thymic hyperplasia by undergoing clinical evaluation and radiological studies. The treatment of hyperthyroidism due to&#x000a0;Graves&#x000a0;disease leads to the rapid resolution of thymic hyperplasia.<xref ref-type="bibr" rid="article-30127.r10">[10]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p><bold>Laboratory studies:</bold>&#x000a0; Acetylcholine receptor antibodies may be positive in some patients with thymic hyperplasia, pointing towards the presence of myasthenia gravis.</p>
        <p><bold>Imaging:</bold>&#x000a0;The thymic hyperplasia is usually discovered&#x000a0;incidentally on radiographical imaging for pre-op of some elective surgery or unrelated chest complaints.&#x000a0; The findings of a chest radiograph can range from subtle mediastinal findings to large mass or widened mediastinum.<xref ref-type="bibr" rid="article-30127.r11">[11]</xref></p>
        <p><bold>Chest X-Ray:</bold>&#x000a0;A frontal chest X-ray of infants and young children show a strikingly large thymus and a sail sign can be seen. The thymus normally remains visible on the radiograph till the age of 3 years. On conventional radiography, thymic hyperplasia usually appears normal.</p>
        <p><bold>Chest CT-scan:</bold>&#x000a0;Contrast-enhanced computed tomography is typically used for thymic abnormalities not detected on conventional radiography. In most cases, chest CT-scan is diagnostic. Chest CT-scan can provide comprehensive information about mediastinal abnormality, inclusive of its&#x000a0;location,&#x000a0;size, relation to surrounding structures, and it can also give you information about the presence of&#x000a0;fluid,&#x000a0;fat, or calcifications within the tissue. CT-scan of a hyperplastic thymus exhibits diffuse enlargement, preserved contour, normal blood vessels, and a mixture of lymphoid tissue and fat. This precise information is important, especially involvement or compression of related structures in order to plan treatment or resection in severe cases.<xref ref-type="bibr" rid="article-30127.r12">[12]</xref></p>
        <p><bold>PET-CT:</bold>&#x000a0;A hyperplastic thymus demonstrates only mild uptake of fluorodeoxyglucose as compared to marked uptake in case of malignancy.&#x000a0;</p>
        <p><bold>Chest MRI:&#x000a0;</bold>Chemical shift MRI usually demonstrates chemical shift artifact between in-phase and out of phase images and can help differentiate thymic hyperplasia from thymic neoplasia. It can be challenging to differentiate between normal and hyperplastic thymus; so following guidelines should be used to identify a normal thymus:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Soft tissue mass should not be greater than 7mm.</p>
          </list-item>
          <list-item>
            <p>The contour of thymus should not be convex in a young adult.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Soft tissue must not be ovulated.</p>
          </list-item>
          <list-item>
            <p>Symptoms of diseases related to thymic hyperplasias such as myasthenia gravis or graves' disease should not be present.<xref ref-type="bibr" rid="article-30127.r13">[13]</xref>&#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Biopsy:&#x000a0;</bold>In the case of&#x000a0;true thymic hyperplasia,&#x000a0;the cortex and medulla are normal. Thymic cells are normal on FNA.&#x000a0;Lymphofollicular&#x000a0;hyperplasia&#x000a0;has normal lymphoid follicles with additional germinal centers, dispersed thymic cells, and a few macrophages.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p><bold>Massive thymic hyperplasia:&#x000a0;</bold>Asymptomatic patients with diffusely enlarged thymus glands can be followed up expectantly because they have a negligible incidence&#x000a0;of significant&#x000a0;thymic disease. The major treatment of<bold>&#x000a0;</bold>massive thymic hyperplasia<bold>&#x000a0;</bold>is <bold>surgical resection</bold>.<xref ref-type="bibr" rid="article-30127.r14">[14]</xref></p>
        <p><bold>Lymphofollicular</bold><bold>&#x000a0;hyperplasia:</bold>&#x000a0;The management of&#x000a0;lymphofollicular&#x000a0;type of thymic hyperplasia depends on how it manifests. Depending upon the signs and symptoms, it could have the following approaches towards treatment.&#x000a0;</p>
        <p><bold>Myasthenia gravis:</bold> Acetylcholinesterase inhibitors&#x000a0;such as physostigmine or pyridostigmine could be used for the symptomatic treatment of myasthenia gravis resulting from thymic hyperplasia. These agents act by inhibiting hydrolysis of acetylcholine in synaptic cleft leading to the availability of more acetylcholine to interact with remaining acetylcholine receptors not yet effected by autoantibodies.&#x000a0;Corticosteroids&#x000a0;can help improve the symptoms of myasthenia gravis, especially in the case of myasthenic crisis. However, the exact mechanism by which steroids act to help with symptoms&#x000a0;has&#x000a0;not been well understood.<xref ref-type="bibr" rid="article-30127.r15">[15]</xref>&#x000a0;Plasma exchange therapy&#x000a0;could also help improve symptoms of myasthenia gravis, and it is relatively less costly.<xref ref-type="bibr" rid="article-30127.r16">[16]</xref>&#x000a0;Thymectomy&#x000a0;is the surgical&#x000a0;removal of the thymus gland. There is evidence that thymectomy leads to remission and decreased drug dependency.&#x000a0;&#x000a0;</p>
        <p><bold>Graves disease:</bold>&#x000a0;Thymic hyperplasia due to Graves' disease usually resolves as the hyperthyroidism is treated and is under control.<xref ref-type="bibr" rid="article-30127.r10">[10]</xref><xref ref-type="bibr" rid="article-30127.r17">[17]</xref></p>
      </sec>
      <sec id="article-30127.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p><bold>Thymolipoma</bold><bold>:&#x000a0;</bold>This accounts for almost 10% of thymic masses, especially in young adults.</p>
          </list-item>
          <list-item>
            <p><bold>Thymoma:</bold>&#x000a0;Accounts for 50% of anterior mediastinal masses and 20% of mediastinal tumors.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Thymic cysts:</bold>&#x000a0;Identified in 3% of patients with an anterior mediastinal mass</p>
          </list-item>
          <list-item>
            <p><bold>Malignant thymoma</bold>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Thymic carcinoid:&#x000a0;</bold>It is a rare disorder found in some patients&#x000a0;with&#x000a0;MEN 1 syndrome.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Thymic germ cell tumor:&#x000a0;</bold>Accounts for 15% of anterior mediastinal masses usually seen in young adults.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Thymectomy has been proven to achieve complete stable remission in patients having myasthenia gravis due to thymic hyperplasia.<xref ref-type="bibr" rid="article-30127.r18">[18]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thymic hyperplasia related to Graves' disease resolves rapidly as the hyperthyroidism gets treated.<xref ref-type="bibr" rid="article-30127.r10">[10]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Overall, thymic hyperplasia has a good prognosis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p><bold>Superior vena cava syndrome:</bold> It is a group of symptoms arising from decreased blood flow from superior vena cava to right atrium leading to swelling of neck, face, and upper limb, dyspnea, cough, headaches, dizziness, lightheadedness. The treatment depends on the&#x000a0;etiology&#x000a0;of obstruction, which in the case of thymic hyperplasia is thymectomy.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Myasthenia gravis</p>
          </list-item>
          <list-item>
            <p>Respiratory distress</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Following consultations should be obtained:</p>
        <list list-type="bullet">
          <list-item>
            <p>Radiologist</p>
          </list-item>
          <list-item>
            <p>Thoracic surgeon&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Neurologist</p>
          </list-item>
          <list-item>
            <p>Endocrinologist</p>
          </list-item>
          <list-item>
            <p>Pathologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with thymic hyperplasia can present differently. The patient could present with compressive symptoms such as dyspnea, dysphagia, cough, horner syndrome, superior vena cava syndrome, or systemic symptoms like weakness and blurry vision due to autoimmune disease like myasthenia gravis. But usually, the thymic hyperplasia is an incidental finding. The newly diagnosed patient should be given emotional support and detailed information about the condition, its treatment, prognosis, and effects on everyday life.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Asymptomatic patient:&#x000a0;</bold>If the thymic hyperplasia is asymptomatic, the patient should be guided about follow up, and observation until the condition remains asymptomatic and steps that will be taken if somehow the condition starts showing symptoms in the future.</p>
          </list-item>
          <list-item>
            <p><bold>Compressive symptoms:</bold> The patients presenting with compressive symptoms should be informed about the cause of symptoms and the possibility of surgery, i.e., thymectomy, to relieve the symptoms.</p>
          </list-item>
          <list-item>
            <p><bold>Myasthenia gravis:</bold> Myasthenia gravis patients should be informed about possible associated between thymic hyperplasia and their condition and the possible need for surgery, i.e., thymectomy in the future to improve their symptoms if the medications and plasma exchange therapy fail to improve the symptoms.</p>
          </list-item>
          <list-item>
            <p><bold>Thymic hyperplasia and Graves disease:</bold> In the case of thymic hyperplasia associated with hyperthyroidism due to grave disease, the patient should be guided that the hyperplasia will subside if hyperthyroidism is controlled.</p>
          </list-item>
        </list>
        <p>The patient should be provided with educational material about the disease. Flow charts, diagrams, and videos should be used to explain each and every aspect of the disease, treatment, and lifestyle changes. Until the patient fully understands everything and is satisfied with the provision of care.</p>
      </sec>
      <sec id="article-30127.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Here are a few important points to take note:</p>
        <list list-type="bullet">
          <list-item>
            <p>The thymus has a major role in T-cell differentiation and maturation.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thymic hyperplasia is the increase in the size of the thymus due to an increase in the number of cells.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thymic hyperplasia could be congenital or acquired,&#x000a0;leading&#x000a0;to&#x000a0;hypo functioning&#x000a0;or hyperfunctioning thymus.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thymic hyperplasia could be due to an increase in the number of thymic epithelial cells or hyperplastic lymphoid follicles.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hyperplastic thymus can cause local symptoms like cyanosis, dyspnea, superior vena cava&#x000a0;syndrome&#x000a0;due to compression of local structures.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>It can also cause systemic symptoms due to autoimmune diseases like myasthenia gravis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>CT-scan or MRI of the chest is used for diagnosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The best&#x000a0;treatment&#x000a0;is&#x000a0;usually&#x000a0;thymectomy.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thymic hyperplasia usually has a good prognosis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30127.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>It is the responsibility of healthcare professionals that the patient has a good understanding of the disease and the appropriate treatment available for the&#x000a0;disease.&#x000a0;Thymic&#x000a0;hyperplasia is&#x000a0;usually an incidental finding and can cause significant anxiety among patients. It is vital for healthcare providers to provide&#x000a0;emotional&#x000a0;support to the newly diagnosed patient. The&#x000a0;approach&#x000a0;to hyperplastic thymus should be&#x000a0;multidisciplinary, including&#x000a0;primary care physician, physician assistant, nurse practitioner, radiologist, pathologist, thoracic surgeon, neurologist, and an endocrinologist in order to establish a definitive diagnosis and provide appropriate treatment.</p>
        <p>If the diagnosis of thymic mass is an incidental finding, a biopsy should be&#x000a0;performed to differentiate thymic hyperplasia from thymoma or other malignancies and make a definitive diagnosis.&#x000a0;Patients who are asymptomatic and have no local or systemic manifestations can be closely monitored by&#x000a0;primary&#x000a0;care providers. Patients with serious manifestations such as superior vena cava&#x000a0;syndrome&#x000a0;or myasthenia gravis should be referred to a thoracic surgeon for thymectomy.</p>
      </sec>
      <sec id="article-30127.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30127&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30127">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/thymic-hyperplasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30127">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30127/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30127">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30127.s17">
        <fig id="article-30127.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Thymic Sail Sign, Medical X-rays thymus sail sign Contributed From Wikimedia User: Nevit Dilmen (CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0/deed.en)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Radiology_1300566_Nevit" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30127.s18">
        <fig id="article-30127.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Contrast-enhanced CT scan shows a solid heart-shaped thymus PMID: 20228326 
Courtesy Clinical and Radiologic review of the Normal and Abnormal Thymus: 
Pearls and Pitfalls 
Nasseri and Eftekhari. Radiographics Vol. 30, No. 2: 413-428 Copyright RSNA, 2010.
(Open Access)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="heart__thymus" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30127.s19">
        <fig id="article-30127.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Thymic hyperplasia in a 40-year-old woman with myasthenia gravis. PMID: 22802894
Courtesy Popa, GA &#x00026; Preda, Emi &#x00026; Scheau, Cristian &#x00026; Vilciu, C &#x00026; Ioana Gabriela, Lupescu. (2012). 
Updates in MRI characterization of the thymus in myasthenic patients. Journal of medicine and life. 5. 206-10. (Open Access)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Thymic-hyperplasia-in-a-40-year-old-woman-with-myasthenia-gravis-Transverse-in-phase" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30127.s20">
        <title>References</title>
        <ref id="article-30127.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rennert</surname>
                <given-names>OM</given-names>
              </name>
            </person-group>
            <article-title>The endocrine thymus.</article-title>
            <source>Ann Clin Lab Sci</source>
            <year>1979</year>
            <season>May-Jun</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-201</page-range>
            <pub-id pub-id-type="pmid">380448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadouri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nevo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Thymic epithelial cell heterogeneity: TEC by TEC.</article-title>
            <source>Nat Rev Immunol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>239</fpage>
            <page-range>239-253</page-range>
            <pub-id pub-id-type="pmid">31804611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Za&#x0012d;rat'iants</surname>
                <given-names>OV</given-names>
              </name>
            </person-group>
            <article-title>[Thymus hyperplasia: classification, problems of patho- and morphogenesis, importance in human pathology].</article-title>
            <source>Arkh Patol</source>
            <year>1991</year>
            <volume>53</volume>
            <issue>10</issue>
            <fpage>3</fpage>
            <page-range>3-12</page-range>
            <pub-id pub-id-type="pmid">1793375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zajratjanc</surname>
                <given-names>OV</given-names>
              </name>
              <name>
                <surname>Serov</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Kuzmenko</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>[The pathogenesis of congenital thymus hyperplasia in children with immune defects].</article-title>
            <source>Zentralbl Allg Pathol</source>
            <year>1990</year>
            <volume>136</volume>
            <issue>7-8</issue>
            <fpage>689</fpage>
            <page-range>689-702</page-range>
            <pub-id pub-id-type="pmid">2089846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ricci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pescarmona</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rendina</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Venuta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruco</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Baroni</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>True thymic hyperplasia: a clinicopathological study.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1989</year>
            <month>May</month>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>741</fpage>
            <page-range>741-5</page-range>
            <pub-id pub-id-type="pmid">2730194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hofmann</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>M&#x000f6;ller</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study.</article-title>
            <source>Klin Wochenschr</source>
            <year>1987</year>
            <month>Jan</month>
            <day>15</day>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-60</page-range>
            <pub-id pub-id-type="pmid">2435953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le Panse</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bismuth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cizeron-Clairac</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cufi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dartevelle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Rosbo</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Berrih-Aknin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Thymic remodeling associated with hyperplasia in myasthenia gravis.</article-title>
            <source>Autoimmunity</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>5-6</issue>
            <fpage>401</fpage>
            <page-range>401-12</page-range>
            <pub-id pub-id-type="pmid">20402580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nunnelee</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Superior vena cava syndrome.</article-title>
            <source>J Vasc Nurs</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-5; quiz 6</page-range>
            <pub-id pub-id-type="pmid">17324762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haider</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gianoukakis</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.</article-title>
            <source>Thyroid</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>8</issue>
            <fpage>994</fpage>
            <page-range>994-1000</page-range>
            <pub-id pub-id-type="pmid">28578595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Popoveniuc</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Devdhar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wexler</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Wartofsky</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.</article-title>
            <source>Thyroid</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>20</volume>
            <issue>9</issue>
            <fpage>1015</fpage>
            <page-range>1015-8</page-range>
            <pub-id pub-id-type="pmid">20718680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Priola</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Priola</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor.</article-title>
            <source>Clin Radiol</source>
            <year>2014</year>
            <month>May</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>e230</fpage>
            <page-range>e230-45</page-range>
            <pub-id pub-id-type="pmid">24581970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasseri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Eftekhari</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls.</article-title>
            <source>Radiographics</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>413</fpage>
            <page-range>413-28</page-range>
            <pub-id pub-id-type="pmid">20228326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Popa</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Preda</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Scheau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vilciu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lupescu</surname>
                <given-names>IG</given-names>
              </name>
            </person-group>
            <article-title>Updates in MRI characterization of the thymus in myasthenic patients.</article-title>
            <source>J Med Life</source>
            <year>2012</year>
            <month>Jun</month>
            <day>12</day>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>206</fpage>
            <page-range>206-10</page-range>
            <pub-id pub-id-type="pmid">22802894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Massive thymic hyperplasia in an adult: A rare case report and literature review.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2018</year>
            <volume>47</volume>
            <fpage>104</fpage>
            <page-range>104-108</page-range>
            <pub-id pub-id-type="pmid">29754034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farmakidis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pasnoor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dimachkie</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Barohn</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Myasthenia Gravis.</article-title>
            <source>Neurol Clin</source>
            <year>2018</year>
            <month>May</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>311</fpage>
            <page-range>311-337</page-range>
            <pub-id pub-id-type="pmid">29655452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Birinder</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic plasma exchange in the treatment of myasthenia gravis.</article-title>
            <source>Indian J Crit Care Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-13</page-range>
            <pub-id pub-id-type="pmid">25624644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Budavari</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Whitaker</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Helmers</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Thymic hyperplasia presenting as anterior mediastinal mass in 2 patients with Graves disease.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2002</year>
            <month>May</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>495</fpage>
            <page-range>495-9</page-range>
            <pub-id pub-id-type="pmid">12005000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30127.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.</article-title>
            <source>Int J Neurosci</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>127</volume>
            <issue>9</issue>
            <fpage>785</fpage>
            <page-range>785-789</page-range>
            <pub-id pub-id-type="pmid">27819773</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
